Cardio Diagnostics Holdings Inc. - Common stock (CDIO)
0.3260
-0.0189 (-5.48%)
NASDAQ · Last Trade: Apr 3rd, 3:01 PM EDT

Via Benzinga · January 22, 2025

Via Benzinga · January 22, 2025

Via Benzinga · December 6, 2024

Via Benzinga · November 6, 2024

Via Benzinga · October 29, 2024

Via Benzinga · October 29, 2024

Via Benzinga · October 29, 2024

Via Benzinga · October 28, 2024

Via Benzinga · October 2, 2024

Via Benzinga · September 27, 2024

Via Benzinga · September 27, 2024

Via Benzinga · September 26, 2024

Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests
Via News Direct · September 17, 2024

CDIO stock results show that Cardio Diagnostics Hldgs beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

CDIO stock results show that Cardio Diagnostics Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · June 21, 2024

Mayumi Kitakata, a Tokyo resident, uses the AI-driven app CatsMe! to monitor the health of her aging cat, reflecting the growing trend of AI in pet healthcare.
Via Benzinga · June 13, 2024

New Study Shows Cardio Diagnostics’ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
Via News Direct · May 7, 2024

Via Benzinga · April 15, 2024

Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests
Via News Direct · April 12, 2024

CDIO stock results show that Cardio Diagnostics Hldgs missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · April 4, 2024

BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strategies for U.S. wealth market.
Via Benzinga · March 8, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via Benzinga · March 5, 2024